This tour will be held, which is related to the Chinese Guidelines for Integrated Diagnosis and Treatment of Cancer
On September 13th, a press conference was held on the release of the Chinese Integrated Diagnosis and Treatment Technology Guidelines for Cancer and the intensive reading tour. The meeting revealed that this weekend, Academician Fan Daiming, Chairman of the China Anti Cancer Association, will lead China's top authoritative cancer experts to gather in Shanghai to hold a lecture on the release of China's integrated cancer diagnosis and treatment technology guidelines and intensive reading.
This guideline is the first integrated diagnosis and treatment guideline for tumors in China. From 2022 to 2023, the China Anti Cancer Association organized more than 13000 authoritative cancer experts to collectively complete the compilation. Covering 53 common tumor types and 60 diagnostic and treatment techniques, there are a total of 113 guidelines. This diagnosis and treatment guide intersects horizontally and vertically, adhering to the cross policy of "prevention screening diagnosis treatment health evaluation support control care", focusing on the epidemiological characteristics, genetic background, original research results, and diagnosis and treatment prevention and control characteristics of the Chinese population. It is included in Chinese research, focusing on Chinese characteristics, considering medical accessibility, reflecting integrated thinking, and is a tumor guideline regulatory system that combines Chinese characteristics and international perspectives, suitable for the Chinese population.
Ni Ming, Secretary General of the Shanghai Anti Cancer Association, stated that from February to September 2023, the China Anti Cancer Association will conduct a nationwide intensive reading tour of the CACA Technical Guidelines, with two sessions per week covering 31 provinces, cities, and autonomous regions across the country. The Shanghai Station event is jointly organized by the Shanghai Anti Cancer Association and Fudan University Affiliated Cancer Hospital. On the afternoon of September 16th, Professor Zhou Caicun, Director of the Oncology Department of Shanghai Pulmonary Hospital, and a team of experts conducted the 59th intensive reading tour on drug clinical research; On the morning of September 17th, Professor Tang Peifu, Director of the Department of Orthopedics at the General Hospital of the People's Liberation Army of China, and a team of experts conducted the 60th intensive reading tour on bone protection. At that time, the intensive reading tour will also be broadcasted through video on the entire network, conveying authoritative knowledge of cancer prevention and treatment to medical workers and the general public.
Professor Chen Zhen, Chairman of the Shanghai Anti Cancer Association and Vice President of Fudan University Affiliated Cancer Hospital, stated that authoritative and scientific diagnosis and treatment guidelines serve as a reference for medical workers to provide scientific diagnosis and treatment plans for cancer patients. It is necessary to develop a series of cancer prevention and treatment guidelines that are suitable for the Chinese population, have grassroots accessibility, clinical operability, and disciplinary system in order to achieve the goal of "Healthy China" cancer prevention and treatment.
Professor Yu Xianjun, chairman of the pancreatic cancer Professional Committee of the Chinese Anti Cancer Association and president of the Cancer Hospital affiliated to Fudan University, said that we are the earliest cancer hospital in China. The hospital has always advocated the standardization of cancer diagnosis and treatment and high-quality transformation of clinical research. In 2005, it took the lead in setting up 12 single disease multidisciplinary comprehensive diagnosis and treatment cooperation groups in China, leading the improvement of the standard of cancer diagnosis and treatment in China. With the completion and opening of the Pudong campus in 2019, the hospital pioneered a disease centered multidisciplinary comprehensive treatment model for tumors nationwide. By opening a multidisciplinary outpatient clinic led by the chief expert of a multidisciplinary team, the efficiency of diagnosing and treating difficult tumor diseases has been greatly improved, forming a multidisciplinary diagnosis and treatment that is accessible to people. Secondly, the Pudong campus has comprehensive wards for breast tumors, pancreatic tumors, and colorectal tumors. While providing patients with the most standardized and beneficial treatment plans, it is also the "source" of many original clinical translational research results, forming many "Shanghai standards" and "Chinese plans" included in international guidelines.
Yu Xianjun stated that the hospital conducted long-term close follow-up on nearly 300000 cancer patients diagnosed with malignant tumors and treated in hospital from 2005 to 2019. The results showed that the overall 5-year survival rate reached 71.1%, leading the country and on par with advanced developed countries in Europe and America. When it comes to the era of precision oncology medicine, Yu Xianjun emphasized that hospitals will use innovation to lead a new round of high-quality development in clinical and scientific research, and further standardize and improve the overall diagnosis and treatment status and level of tumors in China through the release and tour of CACA guidelines by various committees of the China Anti Cancer Association.
![This tour will be held, which is related to the Chinese Guidelines for Integrated Diagnosis and Treatment of Cancer](https://a5qu.com/upload/images/3d9b6c32aad7a01af449b4dd0b68cc23.jpg)
It is understood that the lecture tour has sparked a wave of "learning guidelines, using guidelines, and following standards" nationwide. Next, we will carry out CACA guidelines on campus and grassroots activities, so that the standardized concept of the entire life cycle of cancer diagnosis and treatment can be deeply rooted in people's hearts. Every medical worker engaged in cancer diagnosis and treatment can use standardized diagnosis and treatment concepts and advanced technology to continuously improve the effectiveness of cancer diagnosis and treatment, benefiting patients.
Text: Zhang Qi
*Reprinted from official WeChat account released by Pudong